Could assessment of glioma methylene lipid resonance by in vivo (1)H-MRS be of clinical value?

scientific article

Could assessment of glioma methylene lipid resonance by in vivo (1)H-MRS be of clinical value? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1259/BJR/16316438
P698PubMed publication ID12857705
P5875ResearchGate publication ID237608427

P50authorMartin LeachQ42070326
P2093author name stringBrada M
Dzik-Jurasz AS
Rowland IJ
Murphy PS
Viviers L
P2860cites workIn vivo 1H NMR spectroscopy of an intracerebral glioma in the rat.Q31082382
Detection of metabolic heterogeneity of human intracranial tumors in vivo by 1H NMR spectroscopic imagingQ34496845
Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implicationsQ39495167
Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomasQ40135518
In vivo proton MR spectroscopy of human gliomas: definition of metabolic coordinates for multi-dimensional classification.Q40978170
Diagnostic potential of short echo time MR spectroscopy of gliomas with single-voxel and point-resolved spatially localised proton spectroscopy of brainQ43632743
In vivo single-voxel proton MR spectroscopy in brain lesions with ring-like enhancementQ43765198
Correlation of microvascular permeability derived from dynamic contrast-enhanced MR imaging with histologic grade and tumor labeling index: a study in human brain tumorsQ44263995
In vivo measurement of the size of lipid droplets in an intracerebral glioma in the rat.Q47217270
Diagnostic assessment of brain tumours and non-neoplastic brain disorders in vivo using proton nuclear magnetic resonance spectroscopy and artificial neural networks.Q48190907
Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevanceQ48401235
Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging studyQ48619667
Good practice in the management of adults with malignant cerebral glioma: clinical guidelines. Working Group, Royal College of PhysiciansQ48641248
Tumor angiogenesis of low-grade astrocytomas measured by dynamic susceptibility contrast-enhanced MRI (DSC-MRI) is predictive of local tumor control after radiation therapy.Q48784804
N-acetyl-L-aspartic acid content of human neural tumours and bovine peripheral nervous tissuesQ48800486
Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy.Q49104638
Evaluation of metabolic heterogeneity in brain tumors using 1H-chemical shift imaging method.Q55478971
Determination of proton metabolite concentrations and relaxation parameters in normal human brain and intracranial tumours.Q55480785
P433issue907
P407language of work or nameEnglishQ1860
P304page(s)459-463
P577publication date2003-07-01
P1433published inBritish Journal of RadiologyQ15758529
P1476titleCould assessment of glioma methylene lipid resonance by in vivo (1)H-MRS be of clinical value?
P478volume76

Reverse relations

cites work (P2860)
Q33273666A metabolomics perspective of human brain tumours
Q31061313Applications of magnetic resonance spectroscopy in radiotherapy treatment planning.
Q33622591Chemical shift-based water/fat separation: a comparison of signal models
Q30764446Clinical proton MR spectroscopy in central nervous system disorders
Q30989929Efficacy of proton magnetic resonance spectroscopy in neurological diagnosis and neurotherapeutic decision making
Q64062838Elevated lipid peaks during the recovery phase of Baló's concentric sclerosis: A case report
Q54935926Glycine: a non-invasive imaging biomarker to aid magnetic resonance spectroscopy in the prediction of survival in paediatric brain tumours.
Q44916216In vivo brain macromolecule signals in healthy and glioblastoma mouse models: 1H magnetic resonance spectroscopy, post-processing and metabolite quantification at 14.1 T.
Q34033507In vivo characterization of several rodent glioma models by 1H MRS
Q35738941Inhibition of Pediatric Glioblastoma Tumor Growth by the Anti-Cancer Agent OKN-007 in Orthotopic Mouse Xenografts
Q50581029Lipid metabolism impairment in human gliomas: expression of peroxisomal proteins in human gliomas at different grades of malignancy.
Q36575246Magnetic resonance spectroscopy metabolite profiles predict survival in paediatric brain tumours
Q31144824Neuroimaging of Peptide-based Vaccine Therapy in Pediatric Brain Tumors: Initial Experience
Q48961414Neuroradiological assessment of newly diagnosed glioblastoma
Q46502407Prospective serial proton MR spectroscopic assessment of response to tamoxifen for recurrent malignant glioma
Q46663930Proton MR spectroscopy of cerebral gliomas at 3 T: spatial heterogeneity, and tumour grade and extent
Q46350291Role of advanced MR imaging modalities in diagnosing cerebral gliomas
Q41931195¹H nuclear magnetic resonance spectroscopy characterisation of metabolic phenotypes in the medulloblastoma of the SMO transgenic mice.